MINNEAPOLIS, April 1, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative tools and bioactive reagents for the research and clinical diagnostic communities ...
Bio-Techne Corporation, a global provider of life science research tools, analytical instruments, and diagnostics, today ...
MINNEAPOLIS, Oct. 16, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of proteins, antibodies and Immunoassays today announced that its Wallingford, CT facility has ...
New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. SPYRE™ Amplification Kits leverage sequential and enhanced ...
With a new name and a new CEO, Bio-Techne has begun an aggressive growth strategy to ensure that researchers know not only its flagship brand, R&D Systems, but the company as a whole. One year ago, ...
For example, Bio-Techne’s consumable reagents can be used to build custom enzyme-linked immunosorbent assays (ELISA) and the firm offers a full range of reagents for researchers, ranging from ready-to ...
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results